Ryan J. Watts - 19 Aug 2021 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Signature
/s/ Tyler Nielsen, by power of attorney
Issuer symbol
DNLI
Transactions as of
19 Aug 2021
Transactions value $
-$117,769
Form type
4
Filing time
23 Aug 2021, 20:25:01 UTC
Previous filing
04 Aug 2021
Next filing
03 Sep 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Sale -$80,291 -1,626 -0.07% $49.38 2,177,450 19 Aug 2021 See footnote F1, F2, F3, F4
transaction DNLI Common Stock Sale -$37,477 -750 -0.03% $49.97 2,176,700 19 Aug 2021 See footnote F1, F4, F5
holding DNLI Common Stock 151,691 19 Aug 2021 Direct F3, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy the tax obligations by the reporting person in connection with the settlement of previously vested restricted stock units.
F2 The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $48.81 to $49.80 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
F3 Reflects the issuance of shares to the Watts Family 2015 Trust in connection with the vesting of 5000 restricted stock units held by the Reporting Person.
F4 The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.
F5 The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $49.81 to $50.16 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
F6 Includes 151,691 restricted stock units.